The Role of Pharmacogenetics and Pharmacogenomics in Cancer Chemotherapy with 5-Fluorouracil

Publisher： Karger

E-ISSN： 1423-0313|61|3|199-203

ISSN： 0031-7012

Source： Pharmacology, Vol.61, Iss.3, 2000-09, pp. : 199-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dihydrouracil/Uracil Ratios in Plasma and Toxicities of 5-Fluorouracil-Based Adjuvant Chemotherapy in Colorectal Cancer Patients

By  

Chemotherapy, Vol. 53, Iss. 2, 2007-02 ,pp. : 127-131

Karger

Access to resources Recommend Favorite

Advanced Gastric Cancer with Liver and Lymph Node Metastases Successfully Resected after Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 224-227

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Recurrent Thrombophlebitis in a Colon Cancer Patient with C677T Heterozygous Genotype for MTHFR Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 194-195

Karger

Access to resources Recommend Favorite

Upregulation of Enzymes Metabolizing 5-Fluorouracil in Colorectal Cancer

By  

Chemotherapy, Vol. 53, Iss. 1, 2006-12 ,pp. : 36-41

Karger

Access to resources Recommend Favorite